Acetaminophen GI Label Warnings Justified By Recent Data, Bayer Contends
This article was originally published in The Tan Sheet
Executive Summary
Acetaminophen products should be required to carry gastrointestinal warnings similar to those on aspirin labeling, Bayer Consumer Care asserts
You may also be interested in...
Acetaminophen Dose Reduction Public Health Damage Cited By McNeil
Lowering the highest approved OTC acetaminophen dose would result in pain relief that is "inadequate or of limited duration for many individuals," McNeil Consumer & Specialty Pharmaceuticals tells FDA's Nonprescription Drugs Advisory Committee
Acetaminophen Dose Reduction Public Health Damage Cited By McNeil
Lowering the highest approved OTC acetaminophen dose would result in pain relief that is "inadequate or of limited duration for many individuals," McNeil Consumer & Specialty Pharmaceuticals tells FDA's Nonprescription Drugs Advisory Committee
Acetaminophen Dose Reduction Public Health Damage Cited By McNeil
Lowering the highest approved OTC acetaminophen dose would result in pain relief that is "inadequate or of limited duration for many individuals," McNeil Consumer & Specialty Pharmaceuticals tells FDA's Nonprescription Drugs Advisory Committee